Published in Infect Control Hosp Epidemiol on October 01, 2008
Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22
Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics (2010) 1.88
Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis (2011) 1.36
Preventing hospital-acquired infections: a national survey of practices reported by U.S. hospitals in 2005 and 2009. J Gen Intern Med (2011) 1.23
Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Crit Care (2013) 1.20
Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol (2010) 1.16
Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol (2010) 1.01
The impact of a medical procedure service on patient safety, procedure quality and resident training opportunities. J Gen Intern Med (2013) 0.98
Catheter dwell time and CLABSIs in neonates with PICCs: a multicenter cohort study. Pediatrics (2013) 0.98
Infection prevention in the emergency department. Ann Emerg Med (2014) 0.89
Nursing workload as a risk factor for healthcare associated infections in ICU: a prospective study. PLoS One (2012) 0.88
Molecular investigation of bacterial communities on intravascular catheters: no longer just Staphylococcus. Eur J Clin Microbiol Infect Dis (2014) 0.87
Impact of a multidimensional infection control approach on central line-associated bloodstream infections rates in adult intensive care units of 8 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Ann Clin Microbiol Antimicrob (2013) 0.86
Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial). BMJ Open (2015) 0.83
Antimicrobial activity of B-Lock against bacterial and Candida spp. causing catheter-related bloodstream infections. Antimicrob Agents Chemother (2011) 0.83
A multicenter quasi-experimental study: impact of a central line infection control program using auditing and performance feedback in five Belgian intensive care units. Antimicrob Resist Infect Control (2013) 0.83
Focus on peripherally inserted central catheters in critically ill patients. World J Crit Care Med (2014) 0.82
Current strategies for the prevention and management of central line-associated bloodstream infections. Infect Drug Resist (2010) 0.80
Does the evidence support the SHEA-IDSA recommendation on the use of positive-pressure mechanical valves? Infect Control Hosp Epidemiol (2009) 0.80
Section 5: Dialysis Interventions for Treatment of AKI. Kidney Int Suppl (2011) (2012) 0.79
Does antimicrobial use density at the ward level influence monthly central line-associated bloodstream infection rates? Infect Drug Resist (2014) 0.79
Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy. Eur J Clin Microbiol Infect Dis (2011) 0.79
Demographic and clinical risk factors associated with hospital mortality after isolated severe traumatic brain injury: a cohort study. J Intensive Care (2015) 0.78
A survey of preventive measures used and their impact on central line-associated bloodstream infections (CLABSI) in intensive care units (SPIN-BACC). BMC Infect Dis (2013) 0.78
A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol (2014) 0.78
Perceived strength of evidence supporting practices to prevent health care-associated infection: results from a national survey of infection prevention personnel. Am J Infect Control (2013) 0.78
Reduction in central line-associated bloodstream infections in patients with burns. Infect Control Hosp Epidemiol (2014) 0.77
Hospital-wide multidisciplinary, multimodal intervention programme to reduce central venous catheter-associated bloodstream infection. PLoS One (2014) 0.77
Influence of tracheostomy on the incidence of catheter-related bloodstream infection in the catheterization of jugular vein by posterior access. Eur J Clin Microbiol Infect Dis (2011) 0.76
Introduction to "A Compendium of Strategies To Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 updates". Infect Control Hosp Epidemiol (2014) 0.76
International nosocomial infection control consortium findings of device-associated infections rate in an intensive care unit of a lebanese university hospital. J Glob Infect Dis (2012) 0.75
A Central Line Care Maintenance Bundle for the Prevention of Central Line-Associated Bloodstream Infection in Non-Intensive Care Unit Settings. Infect Control Hosp Epidemiol (2016) 0.75
Second-Generation central venous catheter in the prevention of bloodstream infection: a systematic review. Rev Lat Am Enfermagem (2016) 0.75
Replacement of administration sets used to administer blood, blood products, or lipid emulsions for the prevention of central line-associated bloodstream infection. Infect Control Hosp Epidemiol (2009) 0.75
Skin care practices in newborn nurseries and mother-baby units in Maryland. J Perinatol (2016) 0.75
Closed catheter access system implementation in reducing the bloodstream infection rate in low birth weight preterm infants. Front Pediatr (2015) 0.75
Outbreak column 19: needleless connectors (NCs) tales from nine outbreaks. J Infect Prev (2016) 0.75
Implementation of central line-associated bloodstream infection prevention bundles in a surgical intensive care unit using peer tutoring. Antimicrob Resist Infect Control (2017) 0.75
An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05
Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med (2006) 10.63
Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA (2002) 10.40
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med (2003) 10.40
Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med (2006) 9.17
Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med (2002) 8.67
Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med (2000) 8.32
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med (2013) 7.75
Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol (2008) 7.38
Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med (2010) 7.37
Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med (2015) 7.02
Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis (2003) 6.88
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.70
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Acinetobacter infection. N Engl J Med (2008) 6.47
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol (2005) 5.86
Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med (2001) 5.76
Does this woman have an acute uncomplicated urinary tract infection? JAMA (2002) 5.74
Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet (2006) 5.65
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med (2000) 5.65
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49
Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med (2004) 5.47
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet (2013) 5.43
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis (2008) 4.92
Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis (2009) 4.87
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis (2008) 4.79
Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 4.64
Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control (2011) 4.59
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med (2002) 4.54
Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis (2009) 4.33
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA (2003) 4.09
Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis (2011) 4.09
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis (2003) 4.06
Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med (2005) 4.03
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Effects of work hour reduction on residents' lives: a systematic review. JAMA (2005) 3.97
Impact factor: a valid measure of journal quality? J Med Libr Assoc (2003) 3.95
Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med (2003) 3.74
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis (2007) 3.73
Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med (2006) 3.71
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol (2009) 3.66
A mouse model of Clostridium difficile-associated disease. Gastroenterology (2008) 3.65
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med (2013) 3.40
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis (2003) 3.39
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother (2006) 3.33
Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) (2004) 3.32
Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis (2008) 3.32
Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology (2009) 3.29
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis (2007) 3.15
Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol (2010) 3.10
Graduate medical education and patient safety: a busy--and occasionally hazardous--intersection. Ann Intern Med (2006) 3.03
Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis (2002) 2.99
Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc (2007) 2.90
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med (2007) 2.86
Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect (2007) 2.84
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med (2013) 2.78
Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol (2007) 2.77
Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77
Risk factors for ventilator-associated events: a case-control multivariable analysis. Crit Care Med (2014) 2.77
Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr (2007) 2.75
Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med (2006) 2.71
Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol (2011) 2.71
Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med (2002) 2.68
A call for outcomes research in medical education. Acad Med (2004) 2.67
Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med (2005) 2.67
Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis. Clin Infect Dis (2014) 2.66
Making inpatient medication reconciliation patient centered, clinically relevant, and implementable: a consensus statement on key principles and necessary first steps. Jt Comm J Qual Patient Saf (2010) 2.61
Clinical research during internal medicine residency: a practical guide. Am J Med (2006) 2.61
Liability claims and costs before and after implementation of a medical error disclosure program. Ann Intern Med (2010) 2.59
Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 2.57
Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA (2013) 2.55
Reducing inappropriate urinary catheter use: a statewide effort. Arch Intern Med (2012) 2.55
Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol (2006) 2.52
Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis (2011) 2.49
Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr (2007) 2.48
Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics (2006) 2.46
Advancing the science of patient safety. Ann Intern Med (2011) 2.45
Electronic Support for Public Health: validated case finding and reporting for notifiable diseases using electronic medical data. J Am Med Inform Assoc (2008) 2.44